INTRODUCTION
100%, 12 and in group B 71%; 13 and 20 in each group was calculated and finally increased to 25 in each group.
The cases of CL of age range of 12 years or more were included. Detailed sociodemographic data and clinical data like duration, site, size and number of lesions and presence of secondary infection were also recorded. The diagnosis of CL was made on the basis of history to endemic area and clinical features of erythematous papules, nodule and non healing ulcer and on detection of amastigotes on Giemsa staining on smear taken from the involved site. The cases with allergic to any of these agents, pregnant ladies, children below 12 years, cases with end-stage hepatic or renal failure and those who were taking any treatment for this in the last one month were excluded from this study.
The cases were recruited by simple random sampling divided into two groups, i.e. A and B by random sampling method. Group A was treated with chloroquine in a dose of 250 mg twice daily per oral (10 mg/kg/day) and group B was treated with doxycycline in a dose of 200 mg daily per orally (3.3 mg/kg/day). Patients were followed up fortnightly and examined for number, induration and healing of lesion and inquired about any systemic side effects. Ophthalmic evaluation was done before and after the treatment. Efficacy was labelled as 'yes' where there was complete re-epithelisation or healing with or without scarring of the lesions with no more induration. Patients were called for follow up after three months. Ethical approval was sought from Institutional Review Board and informed verbal consent was taken from every patient before inclusion in the study.
The data was entered and analysed with the help of SPSS version 23. Descriptive statistics were calculated as mean ±5 standard deviation by age and duration of lesions. Effect modifiers were controlled through stratification and post-stratification Chi-square test and independent sample t-test was applied for comparing age and duration of lesions taking p-value less than 0.05 as significant, Chi-square test was applied to compare efficacy of both drugs.
RESULTS
In the present study, there were a total of 50 cases, 25 in each group. As far as descriptive statistic are concerned, mean age in group A and B was 30.56 ±7.14 and 27.96 ±6.97, respectively with p=0.199. There was no significant difference in terms of duration of lesion1.28 ±0.46 versus 1.24 ±0.44 days with p=0.753. All cases were from rural population and endemic areas. There was also no difference in terms of site of lesion; whereas the hand and arms were the most common site in both groups with p=0.34 (Table I ).
The efficacy in group A was 100%, while in group B it was 23 (92%) of cases (Table I ) with p=0.14. Table I reveals duration of treatment of disease was less in chloroquine group. There was no side effect noted in both the groups.
DISCUSSION
CL is prevalent in almost all countries globally and as part of that, it is also found in few endemic areas of Pakistan. 14, 15 Treatment is required due to its complications like disfiguring scar and limited mobility of affected joint and others. 16 This study assessed the efficacy of oral chloroquin and oral tetracycline in treatment of CL.
It is treated by various ways; and among them, antimonials are the most commonly employed modality; but there are few limitations while using it, as it is not easily available, and a significant number of cases suffer from side effects; and the emerging resistance is another point of concern in such cases. 2, 3 Therefore, search for both safer and effective options for treatment of CL continues.
In the present study, the efficacy of the oral chloroquine was 100% as compared to tetracycline, where it was seen in 23 (92%) of the cases with p value of 0.14. It shows that efficacy of both of the two regions is not statistically significantly different, hence either of these can be used in the treatment of CL.
Chloroquine has been found to be effective both oral and intra-lesional in the treatment of CL by Yasmin et al., intra-lesional chloroquine was compared with intralesional meglumine antimoniate, and this treatment was continued for eight weeks and it was seen that the efficacy of chloroquine was 100%. 9 In another study, where oral chloroquine was used in comparison with intra-lesional pentavalent antimony, the efficacy was again found to be 100% with chloroquine, while 93% in the anti-monial group. 10 According to a study done by Hanif et al., they compared intra-lesional and oral chloroquine and it was seen that it was efficacious in 100% of the cases in both the groups. 12 Furthermore, they also revealed that the economic cost was minimal with this and also majority of the cases responded after eight weeks of treatment, which is also observed in our study.
The efficacy of doxycycline was also good in the previous studies. It has not been used previously except once. According to a study done by Mamoudi et al., the efficacy was seen in 10 (71.42%) out of 14 cases reported with leishmaniasis. 13 No significant side effects were seen in previous studies as well as in the present study. Therefore, it can be used as safe and easily available, cost-effective alternative of previous treatment options for cutaneous leishmanisis.
Above mentioned drugs have proven efficacy in the treatment of CL; but there was no direct one-to-one comparison between these two drugs. The present study compares these drugs to find out better option for the treatment of CL. Additionally, number of lesions was not counted in patients.
This study did not include females and children of less than 12 years. There was no placebo group taken in this study, therefore, the possibility of spontaneous cure was not assessed.
CONCLUSION
Oral tetracycline is as efficacious as oral chloroquine in the treatment of cutaneous leishmaniasis.
